Wyeth Submits Marketing Application to FDA for its 13-Valent Vaccine for the Prevention of Pneumococcal Disease in ... (PR Newswire via Yahoo! Finance)
Candidate vaccine designed to protect against the 13 most prevalent serotypes associated with pneumococcal disease -

FDA OKs new Japanese encephalitis vaccine (UPI)
WASHINGTON, March 31 (UPI) -- The U.S. Food and Drug Administration has approved Ixiaro, a vaccine designed to prevent Japanese encephalitis.

Wyeth Submits Marketing Application to FDA for its 13-Valent Vaccine for the Prevention of Pneumococcal Disease in ... (PR Newswire via Yahoo! Finance)
Wyeth Pharmaceuticals, a division of Wyeth , announced today that it has submitted a Biologic License Application to the U.S. Food and Drug Administration for Prevnar 13, Pneumococcal 13-valent Conjugate Vaccine (Diphtheria CRM Protein).